Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MECLIZINE 12.5 MG TABLET

MECLIZINE
$0.0463per EA

Strength

12.5 mg/1

Manufacturer

Aurobindo Pharma Limited

NDC

59651080701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MECLIZINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202640

On Market Since

9/14/2023

Pharmacological Classes

Antiemetic
Emesis Suppression

Price History

1W

0.0%

1M

-1.4%

3M

-3.7%

6M

-6.2%

1Y

-13.5%

3Y

N/A

5Y

N/A

All

-6.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MECLIZINE 25 MG TABLET CHEW
Generic
69618002801•Reliable 1 Laboratories LLC
$0.0311
per EA
MECLIZINE 25 MG TABLET CHEW
Generic
69618002810•Reliable 1 Laboratories LLC
$0.0311
per EA
MECLIZINE 12.5 MG CAPLET
Generic
00536129701•Rugby Laboratories
$0.0313
per EA
MECLIZINE 12.5 MG CAPLET
Generic
00536129710•Rugby Laboratories
$0.0313
per EA
MECLIZINE 12.5 MG TABLET
Generic
24689013801•Apnar Pharma LP
$0.0313
per EA
MECLIZINE 12.5 MG TABLET
Generic
57237033301•Rising Pharma Holdings Inc.
$0.0313
per EA
MECLIZINE 12.5 MG TABLET
Generic
68001052800•BluePoint Laboratories
$0.0313
per EA
MECLIZINE 12.5 MG CAPLET
Generic
69618002701•Reliable 1 Laboratories LLC
$0.0336
per EA
MECLIZINE 12.5 MG CAPLET
Generic
69618002710•Reliable 1 Laboratories LLC
$0.0336
per EA
MECLIZINE 25 MG TABLET CHEW
Generic
00536129901•Rugby Laboratories
$0.0343
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy